Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …

Background: The hepatitis C pandemic has been systematically studied and characterized
in North America and Europe, but this important public health problem has not received …

Background. This paper aims to present cancer incidence rates at national and regional
level of Egypt, based upon results of National Cancer Registry Program (NCRP). Methods …

Summary Background Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global
HCV infections. Because interferon-containing treatments for genotype 4 infection have low …

Egypt is the most affected nation by hepatitis C virus (HCV) and needs a comprehensive
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …

Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New
treatment options are becoming available, and there is a need to characterize the …

Hepatitis C virus genotype 4 (HCV‐4) is the most common variant of the hepatitis C virus
(HCV) in the Middle East and Africa, particularly Egypt. This region has the highest …

BACKGROUND/AIMS: Hepatitis C virus (HCV) is a known risk factor for hepatocellular
carcinoma (HCC), but whether the risk varies among patients infected with different HCV …

Hepatitis C virus (HCV) genotypes 4, 5 and 6 represent> 20% of all HCV cases worldwide.
HCV‐4 is mainly seen in Egypt, where it represents 90% of all HCV cases. Antischistosomal …

The Arab world, stretching from Lebanon and Syria in the north, through to Morocco in the
west, Yemen in the south and Iraq in the east, is the home of more than 300 million people …